Center faculty in the press: Dr. Susruta Majumdar, Ph.D. (Links to an external site)

Center faculty in the press: Dr. Susruta Majumdar, Ph.D.
““What we found through our studies in mice was that the 7-OH metabolite was responsible for inducing most of the pain relief the mice experienced,” said Majumdar. “Through our research, we discovered that the opioid pharmacology of mitragynine is complicated by the role of 7-OH in mediating its activity. In mouse and human liver preparations, the analgesic effects of mitragynine are actually dependent on 7-OH as a metabolic mechanism.” – Dr. Susruta Majumdar, PhD

Center faculty in the press: Dr. Ream Al-Hasani, Ph.D. (Links to an external site)

Center faculty in the press: Dr. Ream Al-Hasani, Ph.D.
“I like to call it the forgotten phase of addiction. I look at the negative effects of relapse and examine what physiological and behavioral changes are happening to drive relapse. I’m also looking at whether less severe withdrawal can prevent relapse. My hope is that if scientists thoroughly understand the neurological effects of withdrawal, they can develop better treatments to help those who are addicted to opioids fully recover from their disease.” – Dr. Ream Al-Hasani, Ph.D.

STLCOP hosts its 10th annual Student Research Symposium

STLCOP hosts its 10th annual Student Research Symposium
Center faculty and research students attended the symposium to present their recent findings in the lab. Their posters and podium presentations highlighted the research projects carried out during the 2018-2019 academic year.

Read the Latest Press on Dr. Majumdar’s Research Featured in Scientific American (Links to an external site)

Read the Latest Press on Dr. Majumdar’s Research Featured in Scientific American
The United States is in the grip of an epidemic. Opioid drugs are powerful pain-relieving medications, but come with a high risk of addiction. According to the Centers for Disease Control and Prevention, 91 Americans die each day from opioid overdoses, and that figure is rising. Dr. Majumdar and colleagues are working to combat the epidemic, but perhaps the frontline science is chemistry.